PIERIS PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Pieris Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2013 to Q2 2024.
  • Pieris Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 1.3M shares, a 18.6% increase year-over-year.
  • Pieris Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 90.1M shares, a 21.4% increase from 2022.
  • Pieris Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 74.2M shares, a 14.9% increase from 2021.
  • Pieris Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 64.5M shares, a 18.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 1.3M +204K +18.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 1.24M +306K +32.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 90.1M +15.9M +21.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 98.9M +24.5M +32.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 1.1M -73M -98.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 931K -72.8M -98.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 74.2M +9.63M +14.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 74.4M +6.67M +9.84% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 74.1M +12.2M +19.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 73.7M +17.4M +30.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 64.5M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 67.7M +13.4M +24.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 61.9M +9.53M +18.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 56.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 54.3M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 52.4M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q3 2014 6.25M +150K +2.46% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-13
Q2 2014 6.1M Apr 1, 2014 Jun 30, 2014 10-K 2014-09-12
Q1 2014 5M Jan 1, 2014 Mar 31, 2014 10-Q 2014-06-02
Q4 2013 5M Oct 1, 2013 Dec 31, 2013 10-Q 2014-05-14
Q3 2013 6.1M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.